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E-mail address: hiroshi.takaku@it-chiba.ac.jp (H. TThe human immunodeﬁciency virus type 1 (HIV-1) long terminal repeat (LTR) contains binding sites
for several host transcription factors that contribute to HIV-1 gene expression. Although previous
reports have indicated that HIV-1 Nef positively or negatively regulates HIV-1 gene expression,
the precise molecular mechanisms by which this occurs remain largely unknown. In this study,
we report that Nef suppressed LTR-driven transcription only in the presence of HIV-1 Tat, which
was localized to the cytoplasm and degraded by the proteasome. However, the depletion of Hsp70
was found to reduce the suppressive effect of Nef on HIV-1 gene expression. These results suggest
that Nef suppresses Hsp70-mediated HIV-1 Tat activation.
Structured summary of protein interactions:
Tat and Nef colocalize by ﬂuorescence microscopy (View interaction)
Hsp70 physically interacts with Tat by anti tag coimmunoprecipitation (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The Nef protein of the human immunodeﬁciency virus type 1
(HIV-1) is a 25–30 kDa myristoylated protein that is expressed
abundantly in the early stages of HIV-1 infection and is known to
be crucial to the pathogenicity of the virus. Nef not only establishes
a host environment that is suitable for viral replication and patho-
genesis but also facilitates the progression from infection to dis-
ease [1–4]. Previous efforts have been focused on exploring how
Nef downregulates host cell receptors, such as the CD4 and the
MHC-1 molecules, thereby helping the virus to lower the defenses
of its host and increasing infectivity [5,6]. Nef also modulates cel-
lular processes, such as apoptosis and signal transduction path-
ways [7]. After signiﬁcant debate regarding its reported negative
[8–10] and positive [11–14] effects on the HIV-1 long terminal re-
peat (LTR) promoter, the Nef protein is now thought to enhance
viral replication and infection through a combination of different
effector functions [4,15–19]. Recent reports have emphasized the
role of Nef in viral gene expression, suggesting that it may oversee
and optimize viral replication. In this role, Nef may enhance Tat-
mediated gene expression at the LTR by activating signaling path-
ways that result in the expression of general transcription factors
and mediating the translocation of repression factors from the nu-
cleus. Thus, Nef may not only enhance infection but also play an
important role in viral replication and pathogenesis.chemical Societies. Published by E
akaku).Recent reports have found that heat shock proteins (HSPs)
interact with viral particles. For instance, Hsp70 is associated with
vesicular stomatitis [20], the vaccinia virus [21], adenovirus [22],
and the gp160 glycoprotein of HIV (during its transportation and
oligomerization) [23]. Nef interacts with Hsp40, resulting in an in-
crease in Hsp40 translocation into the nucleus of the infected cells.
The translocation of Hsp40 appears to facilitate viral gene expres-
sion by regulating LTR-mediated gene expression [14,17].
This paper reports that Nef negatively regulates HIV-1 gene
expression though HIV-1 Tat. In our study, the expression of Nef
signiﬁcantly suppressed the nuclear localization of Tat, leading to
its degradation by the proteasome. Furthermore, Tat activation
by Hsp70 was suppressed by the expression of Nef. The depletion
of Hsp70 reduced this suppressive function of Nef. These results
suggest that Nef suppresses Hsp70-mediated Tat activation.
2. Materials and methods
2.1. Construction of plasmids
The details of the plasmid constructs used in this study are pro-
vided in the Supplementary Materials and Methods section.
2.2. Immunoprecipitation
For this experiment, 293T cells overexpressing FLAG-Hsp70 and
Tat-V5 were lysed in lysis buffer (50 mM Tris–HCl, pH 7.0, 150 mM
NaCl, 1% Nonidet P-40, and 10% glycerol) and incubated with 5 ll
of anti-FLAG antibody (Sigma) and 30 ll of Dynabeads Protein Glsevier B.V. All rights reserved.
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Tween 20. The immunocomplex was eluted by boiling in 20 ll of
2 sample buffer and analyzed using the SDS–PAGE and Western
blot techniques.
2.3. Immunoﬂuorescence microscopy
HeLa cells grown on cover slips were transfected with pTat-V5
and pNef-FLAG using Lipofectamine 2000 Reagent. At 24 h post-
transfection, the cells were treated with DMSO or MG132 for
24 h and were ﬁxed with 4% paraformaldehyde and permeabilized
with 1% Triton X-100. Next, the cells were labeled with primary
antibodies and Alexa-conjugated secondary antibodies and ana-
lyzed via confocal microscopy (Zeiss LSM 5 PASCAL).
2.4. Polyubiquitination assay
The details of the polyubiquitination assay are provided in the
Supplementary Materials and Methods.
3. Results and discussion
3.1. HIV-1 Nef induces the degradation of HIV-1 Tat via the
proteasome-dependent pathway
We initially investigated whether HIV-1 Nef affected HIV-1
gene expression. Speciﬁcally, 293T cells were transfected with
the following plasmids: pNL4-3LucDenv (pNL-Luc) [24], which en-
codes an HIV-1-defective virus containing a reporter gene; lucifer-
ase in place of Nef in the HIV-1NL4-3 molecular clone; and an
empty plasmid or pNef-V5. The expression of Nef decreased lucif-Fig. 1. Tat-mediated transactivation of the HIV-1 LTR is suppressed by Nef. (A) For
this experiment, 293T cells were transfected with 250 pg of pNL-Luc along with
250 pg of pCMV-renilla-Luc and increasing amounts of pNef-V5 (0, 50 or 250 ng,
adjusted with an empty plasmid to 250 ng of total DNA). At 48 h post-transfection,
the level of ﬁreﬂy luciferase activity was determined using a luciferase assay. Fireﬂy
luciferase activity was normalized to renilla luciferase activity. (B and C) 293T cells
were transfect with 250 pg of pLTR-ﬁreﬂy-Luc along with 250 pg of pCMV-renilla-
Luc and increasing amounts of pNef-V5 (0, 50 or 250 ng, adjusted with an empty
plasmid to 250 ng of total DNA) in the absence (B) or presence (C) of 25 ng of pTat-
V5. At 48 h post-transfection, the luciferase assay was performed as described in
Fig. 1A. (D) Next, 293T cells were transfected with 500 ng of pTat-V5 and 500 ng of
either an empty plasmid or pNef-V5. At 48 h post transfection, cell lysates were
analyzed by Western blot.erase activity in a dose-dependent manner (Fig. 1A). To address
whether this effect was due to the suppression of HIV-1 LTR activ-
ity by Nef, we used an LTR-driven luciferase reporter plasmid
(pLTR-Luc). There were no signiﬁcant effects on LTR-driven tran-
scription as a result of Nef expression (Fig. 1B). These data suggest
that Nef does not directly suppress LTR-driven transcription and
that the suppressive function of Nef is mediated by one or more
viral proteins. Therefore, we next investigated whether Nef sup-
pressed HIV-1 Tat. Nef expression suppressed luciferase activity
in 293T cells that also expressed Tat (Fig. 1C). Therefore, the sup-
pression of HIV-1 gene expression by Nef was dependent on Tat
expression. To address further whether the effects observed were
due to the Nef-mediated suppression of Tat gene expression, we
analyzed Tat expression levels using the Western blot technique.
The level of exogenous Tat expression was signiﬁcantly lower in
pNef-V5-transfected cells than in mock-transfected cells
(Fig. 1D). To determine the molecular mechanism by which Nef
suppressed Tat expression, we used several inhibitors of the ubiq-
uitin-proteasome and endosome pathways. Treatment with an
endosome inhibitor (NH4Cl) had no effect on the Nef-mediated
suppression of Tat (Fig. 2A; compare DMSO to NH4Cl). However,
Tat expression was restored upon treatment with a proteasome
inhibitor (MG-132). Treatment with MG-132 also led to the accu-
mulation of ubiquitinated forms of Tat in Nef-expressing cells
(Fig. 2B). To address further whether MG132 restored Tat-driven
LTR transcription, Nef-expressing cells were treated with MG132
in the presence of Tat (Fig. 2C). Although Nef decreased the level
of luciferase activity in a Tat-dependent manner, treatment with
MG132 restored Tat-driven LTR transcription to the level observed
in Nef-negative cells.
Next, we analyzed Tat localization in the absence or presence of
Nef via immunoﬂuorescence microscopy. As in previous research,
the nuclear localization of Tat was observed in cells in the absence
of Nef (Fig. 2D). In contrast, the expression of Nef induced the cyto-
plasmic localization of Tat, and the two proteins were co-localized
in the cytoplasm. Signiﬁcantly, treatment with MG132 restored the
nuclear localization of Tat in Nef-expressing cells. These results
suggest that Nef induces the cytoplasmic localization of Tat and
mediates the degradation of the Tat protein via the ubiquitin-pro-
teasome-dependent pathway.
3.2. The myristoylation of Nef is required for Tat degradation
To determine which region of Nef was associated with the deg-
radation of Tat, we introduced mutations into the functional motifs
of Nef (Fig. S1A). The Nef-E4A4 [25], -P4A4 [26], -LLAA [27–28],
and -AxxA [29–30] mutants, along with wild-type Nef, suppressed
NL-Luc gene expression (Fig. S1B). In contrast, Nef-G2A [29] im-
paired the suppression of NL-Luc gene expression and failed to in-
duce Tat degradation (Fig. S1C). These results suggest that the
myristoylation of Nef is important to HIV-1 gene expression.
3.3. Nef inhibits Tat activation by Hsp70
Hsp70 is a general chaperone protein that assists in protein sta-
bilization and folding. In a previous report, the chaperone activity
of Hsp70 was shown to be required for the stabilization of P-TEFb,
which is a known Tat co-factor [31]. Therefore, to examine whether
Nef suppressed Hsp70-mediated Tat activation, 293T cells were
transfected with pNL-Luc along with an empty plasmid or
pFLAG-Hsp70. At 48 h post-transfection, the level of luciferase
activity was determined using a luciferase assay. The expression
of Hsp70 signiﬁcantly enhanced pNL-Luc gene expression in a
dose-dependent manner (Fig. 3A). However, Hsp70 had little effect
on LTR-driven transcription (Fig. 3B). Signiﬁcantly, the expression
of Hsp70 in cells expressing Tat enhanced LTR-driven gene expres-
Fig. 2. Nef induces the degradation of Tat via the proteasome-dependent pathway. (A) For this experiment, 293T cells were transfected with 500 ng of pTat-V5 and 500 ng of
either an empty plasmid or pNef-V5. At 24 h post-transfection, cells were treated with DMSO, 10 mM NH4Cl or 5 lM MG132. After 24 h of treatment, cell lysates were
analyzed by Western blot. (B) Next, 293T cells were transfected with 2 lg of pCMV-Myc-Ubi, 2 lg of pTat-V5 and 2 lg of either an empty plasmid or pNef-FLAG. At 24 h post-
transfection, cells were treated with 5 lM MG132. After 24 h, cell lysates were immunoprecipitated with an anti-Myc antibody followed by immunoblotting with a
horseradish peroxidase-conjugated anti-HA antibody. (C) Furthermore, 293T cells were transfected with 250 pg of pLTR-ﬁreﬂy-Luc, 250 pg of pCMV-renilla-Luc, 25 ng of
pTat-V5 and 250 pg of either an empty plasmid or pNef-V5. At 24 h post-transfection, cells were treated with 5 lMMG132. After 24 h, the luciferase assay was performed as
described in Fig. 1A. (D) HeLa cells were transfected with pTat-V5 in the absence or presence of pNef-FLAG. At 24 h post-transfection, cells were treated with DMSO or 5 lM
MG132. After 24 h, the cells were analyzed by immunoﬂuorescence microscopy. Green: Tat-V5, Red: Nef-FLAG, Blue: DAPI
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cated that Hsp70 bound to Tat (Fig. 3D). To investigate the effect
of Nef on Hsp70-mediated Tat activation, 293T cells were transfec-
ted with pFLAG-Hsp70, pTat-V5 and either an empty plasmid or
pNef-V5. Although the expression of Hsp70 in Tat-transfected cells
signiﬁcantly increased the level of luciferase activity, the expres-
sion of Nef (50 ng) counteracted the effect of Hsp70 on Tat activa-
tion (Fig. 3E). Moreover, higher levels of expression of Nef (250 ng)
led to an additional decrease in luciferase activity, probably be-
cause of the inhibition of both endogenous and exogenous
Hsp70. These results suggest that Nef suppresses Hsp70-mediated
Tat activation.3.4. The suppressive function of Nef on Tat activation is diminished in
Hsp70-depleted cells
To examine the effect of endogenous Hsp70 on Tat activation,
the expression of endogenous Hsp70 was reduced using a speciﬁc
small interfering RNA (siRNA) construct in 293T cells. The Hsp70
knockdown was efﬁcient as indicated by the Western blot analysis
(Fig. 4A). The Hsp70 knockdown had no effect on LTR-driven tran-
scription in the absence of Tat (Fig. 4B). However, the Hsp70
knockdown in 293T cells expressing Tat signiﬁcantly reduced the
level of luciferase activity as compared with that of the siCon-
trol-treated cells expressing Tat. To further address whether Nef
Fig. 3. HIV-1 Nef inhibits Hsp70-mediated HIV-1 gene expression. (A–C) For this experiment, 293T cells were transfected with 250 pg of pNL-Luc (A) or 250 pg of pLTR-
ﬁreﬂy-Luc (B, C) along with 250 pg of pCMV-renilla-Luc and increasing amounts of pFLAG-Hsp70 (0, 250 or 500 ng, adjusted with an empty plasmid to 500 ng of total DNA) in
the absence (A and B) or presence (C) of pTat-V5. The luciferase assay was performed as described in Fig. 1A. (D) Next, 293T cells were transfected with 100 ng of pTat-V5 and
1 lg of either an empty plasmid or pFLAG-Hsp70. At 48 h post-transfection, cell lysates were immunoprecipitated with an anti-FLAG antibody followed by Western blot
analysis with an anti-V5 antibody. (E) Finally, 293T cells were transfected with 250 pg of pLTR-ﬁreﬂy-Luc, 250 pg of pCMV-renilla-Luc, 25 ng of pTat-V5, either 500 ng of
pFLAG-Hsp70 or 500 ng of an empty plasmid, and increasing amounts of pNef-V5 (0, 50 or 250 ng, adjusted with an empty plasmid to 250 ng of total DNA). The luciferase
assay was performed as described in Fig. 1A.
Fig. 4. Suppression of the HIV-1 LTR by Nef is dependent on Hsp70. (A) For this experiment, 293T cells were treated with 70 nM Hsp70-siRNA (siHsp70) or 70 nM control-
siRNA (siControl). At 24 h post-transfection, cell lysates were analyzed by Western blot using the indicated antibodies. (B) Next, 293T cells were treated with 70 nM siHsp70
or 70 nM siControl. Twenty-four hours after transfection, cells were transfected with 250 pg of pLTR-ﬁreﬂy-Luc, 250 ng of pCMV-renilla-Luc, 25 ng of pTat-V5 and 250 ng of
either an empty plasmid or pNef-V5. The luciferase assay was performed as described in Fig. 1A. The values within the graph represent the fold change in luciferase activity.
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of Tat, we used Hsp70-knockdown cells. When the 293T cells were
transfected with siControl, the expression of Nef yielded a 10-fold
reduction in luciferase activity compared with that of the mock-
transfected cells. However, in cells transfected with siHsp70, Nefexpression had little effect on Tat-driven LTR transcription (exhib-
iting a 2-fold reduction). These results indicate that Nef’s suppres-
sion of Tat activation is dependent on Hsp70 expression.
In summary, we conclude that HIV-1 Nef shifts Tat from the nu-
cleus to the cytoplasm and induces the proteasome-dependent
R. Sugiyama et al. / FEBS Letters 585 (2011) 3367–3371 3371degradation of Tat, thereby resulting in the inhibition of HIV-1
gene expression. Moreover, Nef suppresses Hsp70-mediated Tat
activation, and the suppressing effect of Nef on Tat is dependent
on Hsp70 expression. These results may serve as the basis for novel
approaches to the development of HIV-1 inhibitors that target
Hsp70 and Tat.
Acknowledgments
We thank Drs. M. Kannagi and T. Hayashi for providing pNef-V5
and its mutants, Dr. I.S.Y. Chen for providing pNL4-3lucDenv and
Dr. A. Ryo for providing pCMV-Myc-Ubi. This work was supported
in part by a Grant-in-Aid for High Technology Research (no.
09309011) from the Ministry of Education, Science, Sports, and
Culture in Japan, by a Grant-in-Aid for AIDS research from the Min-
istry of Health, Labor, and Welfare in Japan, and by a Grant from
the Ministry of Education, Culture, Sports, Science, and Technology
in Japan (MEXT) as part of the Strategic Research Foundation
Grant-Aided Project for Private Universities.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2011.09.029.
References
[1] Guy, B., Kieny, M.P., Riviere, Y., Le Peuch, C., Dott, K., Girard, M., Montagnier, L.
and Lecocq, J.P. (1987) HIV F/30 orf encodes a phosphorylated GTP-binding
protein resembling an oncogene product. Nature 330, 266–269.
[2] Kestler 3rd, H.W., Ringler, D.J., Mori, K., Panicali, D.L., Sehgal, P.K., Daniel, M.D.
and Desrosiers, R.C. (1991) Importance of the nef gene for maintenance of high
virus loads and for development of AIDS. Cell 65, 651–662.
[3] Klotman, M.E., Kim, S., Buchbinder, A., DeRossi, A., Baltimore, D. and Wong-
Staal, F. (1991) Kinetics of expression of multiply spliced RNA in early human
immunodeﬁciency virus type 1 infection of lymphocytes and monocytes. Proc.
Natl. Acad. Sci. USA 88, 5011–5015.
[4] Simmons, A., Aluvihare, V. and McMichael, A. (2001) Nef triggers a
transcriptional program in T cells imitating single-signal T cell activation
and inducing HIV virulence mediators. Immunity 14, 763–777.
[5] Renkema, G.H. and Saksela, K. (2000) Interactions of HIV-1 NEF with cellular
signal transducing proteins. Front. Biosci. 5, D268–D283.
[6] Oldridge, J. and Marsh, M. (1998) Nef – an adaptor adaptor? Trends Cell Biol. 8,
302–305.
[7] Rasola, A., Gramaglia, D., Boccaccio, C. and Comoglio, P.M. (2001) Apoptosis
enhancement by the HIV-1 Nef protein. J. Immunol. 166, 81–88.
[8] Niederman, T.M., Thielan, B.J. and Ratner, L. (1989) Human immunodeﬁciency
virus type 1 negative factor is a transcriptional silencer. Proc. Natl. Acad. Sci.
USA 86, 1128–1132.
[9] Ahmad, N. and Venkatesan, S. (1988) Nef protein of HIV-1 is a transcriptional
repressor of HIV-1 LTR. Science 241, 1481–1485.
[10] Arora, V.K., Fredericksen, B.L. and Garcia, J.V. (2002) Nef: agent of cell
subversion. Microbes. Infect. 4, 189–199.
[11] Joseph, A.M., Ladha, J.S., Mojamdar, M. and Mitra, D. (2003) Human
immunodeﬁciency virus-1 Nef protein interacts with Tat and enhances HIV-
1 gene expression. FEBS Lett. 548, 37–42.[12] Kim, S., Ikeuchi, K., Byrn, R., Groopman, J. and Baltimore, D. (1989) Lack of a
negative inﬂuence on viral growth by the nef gene of human
immunodeﬁciency virus type 1. Proc. Natl. Acad. Sci. USA 86, 9544–9548.
[13] Murphy, K.M., Sweet, M.J., Ross, I.L. and Hume, D.A. (1993) Effects of the tat
and nef gene products of human immunodeﬁciency virus type 1 (HIV-1) on
transcription controlled by the HIV-1 long terminal repeat and on cell growth
in macrophages. J. Virol. 67, 6956–6964.
[14] Rawat, P. and Mitra, D. (2011) Cellular heat shock factor 1 positively regulates
human immunodeﬁciency virus-1 gene expression and replication by two
distinct pathways. Nucleic Acids. Res. 39, 5879–5892.
[15] Papkalla, A., Munch, J., Otto, C. and Kirchhoff, F. (2002) Nef enhances human
immunodeﬁciency virus type 1 infectivity and replication independently of
viral coreceptor tropism. J. Virol. 76, 8455–8459.
[16] Lundquist, C.A., Zhou, J. and Aiken, C. (2004) Nef stimulates human
immunodeﬁciency virus type 1 replication in primary T cells by enhancing
virion-associated gp120 levels: coreceptor-dependent requirement for Nef in
viral replication. J. Virol. 78, 6287–6296.
[17] Kumar, M. and Mitra, D. (2005) Heat shock protein 40 is necessary for human
immunodeﬁciency virus-1 Nef-mediated enhancement of viral gene
expression and replication. J. Biol. Chem. 280, 40041–40050.
[18] Glushakova, S., Grivel, J.C., Suryanarayana, K., Meylan, P., Lifson, J.D.,
Desrosiers, R. and Margolis, L. (1999) Nef enhances human
immunodeﬁciency virus replication and responsiveness to interleukin-2 in
human lymphoid tissue ex vivo. J. Virol. 73, 3968–3974.
[19] Wolf, D., Witte, V., Clark, P., Blume, K., Lichtenheld, M.G. and Baur, A.S. (2008)
HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-
nucleated signaling complex. Cell. Host. Microbe 4, 398–408.
[20] Hammond, C. and Helenius, A. (1994) Folding of VSV G protein: sequential
interaction with BiP and calnexin. Science 266, 456–458.
[21] Jindal, S. and Young, R.A. (1992) Vaccinia virus infection induces a stress
response that leads to association of Hsp70 with viral proteins. J. Virol. 66,
5357–5362.
[22] Macejak, D.G. and Luftig, R.B. (1991) Association of Hsp70 with the adenovirus
type 5 ﬁber protein in infected HEp-2 cells. Virology 180, 120–125.
[23] Otteken, A., Earl, P.L. and Moss, B. (1996) Folding, assembly, and intracellular
trafﬁcking of the human immunodeﬁciency virus type 1 envelope
glycoprotein analyzed with monoclonal antibodies recognizing maturational
intermediates. J. Virol. 70, 3407–3415.
[24] Planelles, V., Bachelerie, F., Jowett, J.B., Haislip, A., Xie, Y., Banooni, P., Masuda,
T. and Chen, I.S. (1995) Fate of the human immunodeﬁciency virus type 1
provirus in infected cells: a role for vpr. J. Virol. 69, 5883–5889.
[25] Piguet, V., Wan, L., Borel, C., Mangasarian, A., Demaurex, N., Thomas, G. and
Trono, D. (2000) HIV-1 Nef protein binds to the cellular protein PACS-1 to
downregulate class I major histocompatibility complexes. Nat. Cell. Biol. 2,
163–167.
[26] Yamada, T., Kaji, N., Odawara, T., Chiba, J., Iwamoto, A. and Kitamura, Y. (2003)
Proline 78 is crucial for human immunodeﬁciency virus type 1 Nef to down-
regulate class I human leukocyte antigen. J. Virol. 77, 1589–1594.
[27] Letourneur, F. and Klausner, R.D. (1992) A novel di-leucine motif and a
tyrosine-based motif independently mediate lysosomal targeting and
endocytosis of CD3 chains. Cell 69, 1143–1157.
[28] Pond, L., Kuhn, L.A., Teyton, L., Schutze, M.P., Tainer, J.A., Jackson, M.R. and
Peterson, P.A. (1995) A role for acidic residues in di-leucine motif-based
targeting to the endocytic pathway. J. Biol. Chem. 270, 19989–19997.
[29] Fackler, O.T., Luo, W., Geyer, M., Alberts, A.S. and Peterlin, B.M. (1999)
Activation of Vav by Nef induces cytoskeletal rearrangements and
downstream effector functions. Mol. Cell. 3, 729–739.
[30] Saksela, K., Cheng, G. and Baltimore, D. (1995) Proline-rich (PxxP) motifs in
HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for
the enhanced growth of Nef+ viruses but not for down-regulation of CD4.
EMBO. J. 14, 484–491.
[31] O’Keeffe, B., Fong, Y., Chen, D., Zhou, S. and Zhou, Q. (2000) Requirement for a
kinase-speciﬁc chaperone pathway in the production of a Cdk9/cyclin T1
heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1
transcription. J. Biol. Chem. 275, 279–287.
